Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) insider Sean Mcnealy sold 75,800 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was sold at an average price of $8.00, for a total value of $606,400.00. Following the completion of the sale, the insider now directly owns 12,361,500 shares of the company’s stock, valued at approximately $98,892,000. This represents a 0.61 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.
Abacus Life Stock Performance
Shares of ABL stock traded up $0.08 on Monday, hitting $7.80. The company had a trading volume of 178,722 shares, compared to its average volume of 94,269. The company has a 50-day moving average price of $8.46 and a 200-day moving average price of $9.31. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.65. The firm has a market cap of $660.50 million, a P/E ratio of -43.33 and a beta of 0.13. Abacus Life, Inc. has a twelve month low of $7.07 and a twelve month high of $13.25.
Abacus Life (NASDAQ:ABL – Get Free Report) last posted its earnings results on Thursday, November 7th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.06. The firm had revenue of $28.15 million for the quarter, compared to analysts’ expectations of $26.08 million. Abacus Life had a positive return on equity of 12.88% and a negative net margin of 11.65%. During the same period last year, the firm earned $0.01 EPS. As a group, equities research analysts predict that Abacus Life, Inc. will post 0.64 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Abacus Life
Analyst Ratings Changes
Several analysts have weighed in on ABL shares. B. Riley boosted their target price on shares of Abacus Life from $16.00 to $17.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Northland Securities assumed coverage on Abacus Life in a research report on Thursday, October 24th. They issued an “outperform” rating and a $13.50 target price on the stock. B. Riley Financial reaffirmed a “buy” rating and set a $16.00 price target on shares of Abacus Life in a research report on Friday, August 30th. Northland Capmk raised Abacus Life to a “strong-buy” rating in a report on Thursday, October 24th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $13.00 target price (up previously from $12.00) on shares of Abacus Life in a report on Friday, November 8th. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, Abacus Life has a consensus rating of “Buy” and an average target price of $14.70.
Check Out Our Latest Report on ABL
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Read More
- Five stocks we like better than Abacus Life
- Health Care Stocks Explained: Why You Might Want to Invest
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- 3 Tickers Leading a Meme Stock Revival
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- How to Calculate Inflation Rate
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.